Diamyd Medical AB reported consolidated and parent earnings results for the first quarter ended November 30, 2011. For the first quarter, on consolidated basis, the company reported total net sales amounted to SEK 0.1 million compared to SEK 144.5 million a year ago. Loss before tax amounted to SEK 7.4 million compared to profit before tax of SEK 98.3 million a year ago. Net loss was SEK 7.69 million or SEK 0.26 per share before dilution and after dilution compared to net profit of SEK 98.33 million or SEK 3.32 per share after dilution last year. Total operating income was SEK 2.63 million compared to SEK 144.47 million last year. Operating loss was SEK 13.26 million compared to operating profit of SEK 96.81 million last year. Net cash used in operating activities was SEK 24.29 million compared to SEK 39.07 million last year. Return on equity was negative 1.7% compared to return on equity of 26.4% last year. Cash flow per share was negative SEK 0.1 compared to cash flow per share of SEK 16.4 last year. For the quarter, on parent basis, the company reported total operating income of SEK 0.54 million compared to SEK 144.47 million for the same period a year ago. Operating loss was SEK 3.68 million compared to operating profit of SEK 116.67 million last year. Profit before tax was SEK 1.06 million compared to SEK 99.49 million a year ago. Net profit was SEK 1.06 million compared to net profit of SEK 99.49 million last year.